L-DOPA alone contributed to strong recovery of motion phenotypes during initial phase, however, its effect lagged in aged flies which showed movement defects similar to untreated park13 mutants (Fig. 5e), probably due to dyskinesia usually associated with protracted L-DOPA exposure. Here, HTRA2 is linked to drug-induced dyskinesia.